Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma.
| Image |  |
|---|---|
| Description | scientific article published on 14 December 2012 |
| Author/s |
author: John F Seymour Simon Harrison |
| Publication date | December 14, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |